TAVA Technologies (TAVA-NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TAVA Technologies (TAVA-NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote (28805)	2/24/1999 11:24:00 AM
From: Manzanillo	Read Replies (1) of 31646

<<The TAVA fraud issues another misleading press release.>>Bill Wexler Bill, back in August you used the same argument against ZONAGEN (ZONA) predicting that it was going to trade under $5, that it was all a fraud, that Vasomax didn't work, that it would never be approved by the FDA, etc. etc. The stock was then selling at around 17. Here is what happened yesterday: << Schering-Plough obtained global marketing rights to Vasomax from Texas-based Zonagen Inc <ZONA.O> in 1997. The active ingredient of the product, phentolamine, has previously been marketed by other drug makers as a treatment for hypertension. Shares of both companies rose Tuesday after they confirmed that Schering-Plough had begun to scale up production of Vasomax. Schering-Plough closed up 2-3/16 to 55-1/4, while Zonagen climbed 2-1/8 to 28-5/8. >>Reuters I think the only fraud around here is you. You want to sound like an expert in many subjects, without having any idea of what you are talking about.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next